These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8965738)

  • 41. Preventing occupational exposures to antineoplastic drugs in health care settings.
    Connor TH; McDiarmid MA
    CA Cancer J Clin; 2006; 56(6):354-65. PubMed ID: 17135692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Risk perception and self-assessment of exposure to antineoplastic agents in a group of nurses and pharmacists].
    Vollono C; Badoni G; Petrelli G
    G Ital Med Lav Ergon; 2002; 24(1):49-55. PubMed ID: 11892417
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hazardous drugs.
    Black LA; Presson AC
    Occup Med; 1997; 12(4):669-85. PubMed ID: 9353816
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Health surveillance activity and characterization of exposure to low levels of chromium: results of a 10-year follow-up].
    Cardoni F; Simonazzi S; Bova M; Ricciardi Tenore G
    G Ital Med Lav Ergon; 2003; 25 Suppl(3):83-4. PubMed ID: 14979095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevention of risks from occupational exposure to antineoplastic drugs. Consensus document.
    Alessio L; Apostoli P; Draicchio F; Forni A; Lucchini R; Merler E; Palazzo S; Scarselli R; Sossai D
    Med Lav; 1996; 87(3):194-206. PubMed ID: 8965733
    [No Abstract]   [Full Text] [Related]  

  • 46. Occupational risk factors and reproductive health of women.
    Figà-Talamanca I
    Occup Med (Lond); 2006 Dec; 56(8):521-31. PubMed ID: 17151388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reproductive risks associated with exposure to antineoplastic agents: a review of the literature.
    Hoffman DM
    Hosp Pharm; 1986 Oct; 21(10):930-2, 936, 940. PubMed ID: 10301074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The influence of nurses' knowledge, attitudes, and health beliefs on their safe behavior with cytotoxic drugs in Israel.
    Ben-Ami S; Shaham J; Rabin S; Melzer A; Ribak J
    Cancer Nurs; 2001 Jun; 24(3):192-200. PubMed ID: 11409063
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Health surveillance of subjects formerly exposed to asbestos in Puglia].
    Luisi V; Dario R; Mera E; Mininni F; Molinini R
    G Ital Med Lav Ergon; 2006; 28(2):166-8. PubMed ID: 16805448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Can occupational medical surveillance work for healthcare workers?
    Healthc Hazard Mater Manage; 2000 Apr; 13(8):1-4. PubMed ID: 10977626
    [No Abstract]   [Full Text] [Related]  

  • 51. Radiation in the workplace-a review of studies of the risks of occupational exposure to ionising radiation.
    Wakeford R
    J Radiol Prot; 2009 Jun; 29(2A):A61-79. PubMed ID: 19454806
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reproductive health risks associated with occupational exposures to antineoplastic drugs in health care settings: a review of the evidence.
    Connor TH; Lawson CC; Polovich M; McDiarmid MA
    J Occup Environ Med; 2014 Sep; 56(9):901-10. PubMed ID: 25153300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Regulation and duties for the radiation protection physician in medical surveillance of exposed to AOR].
    Moccaldi R; Pennarola R
    G Ital Med Lav Ergon; 2011; 33(3 Suppl):395-8. PubMed ID: 23393885
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The epidemiological health surveillance of the working conditions for servicemen in weapons and military equipment parks].
    Sergeev SM
    Voen Med Zh; 1995 Oct; (10):59-62. PubMed ID: 8533366
    [No Abstract]   [Full Text] [Related]  

  • 55. Occupational exposure to antiproliferative drugs in health care workers.
    Dominici C; Börzsönyi M; Caroli S; Petrucci F; Castello MA
    Ann Ist Super Sanita; 1989; 25(4):601-4. PubMed ID: 2698603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The prevention of work risks deriving from the use of chemotherapeutic antineoplastics in the health environment: the consensus document (November 1995)].
    Med Lav; 1996; 87(1):78-86. PubMed ID: 8699986
    [No Abstract]   [Full Text] [Related]  

  • 57. Biomonitoring of occupational exposures to cytostatic anticancer drugs.
    Bos RP; Sessink PJ
    Rev Environ Health; 1997; 12(1):43-58. PubMed ID: 9128910
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drinking habits and occupational exposure to xenobiotics: a review.
    Bisio S; Franco G
    G Ital Med Lav; 1995; 17(1-6):37-40. PubMed ID: 8940655
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exposure to hazardous drugs in healthcare: an issue that will not go away.
    Davis J; McLauchlan R; Connor TH
    J Oncol Pharm Pract; 2011 Mar; 17(1):9-13. PubMed ID: 21372152
    [No Abstract]   [Full Text] [Related]  

  • 60. [Risks encountered by personnel using cytotoxic drugs].
    Vin M
    Soins Gynecol Obstet Pueric Pediatr; 1992; (135-136):54-9. PubMed ID: 1481002
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.